Epinephrine has been shown to be a first-choice drug for cardiopulmonary resuscitation. Nevertheless, its β-adrenergic effect probably increases myocardial oxygen consumption and leads to severe cardiac and cerebral injuries; moreover, epinephrine does not elevate long-term survival rates. The American Heart Association and the European Resuscitation Council recently recommended that vasopressin can be used for cardiopulmonary resuscitation, instead of epinephrine. However, the guidelines do not discuss the effects of vasopressin during cerebral resuscitation. According to a recent study reported in the Neural Regeneration Research, Chinese scholars found that vasopressin alone or the vasopressin and epinephrine combination suppress the activation of mitogen-activated protein kinase and c-Jun N-terminal kinase signaling pathways and reduce neuronal apoptosis during cardiopulmonary resuscitation, which is of great significance for improving the successful rate of cardiopulmonary resuscitation.
Article: " Vasopressin decreases neuronal apoptosis during cardiopulmonary resuscitation," by Chi Ma1, Zhe Zhu2, Xu Wang3, Gang Zhao1, Xiaoliang Liu4, Rui Li2 (1 Department of Neurosurgery, the First Hospital, Jilin University, Changchun, Jilin Province, China; 2 Center for Hand and Foot Surgery and Reparative and Reconstructive Surgery, Orthopedics Hospital, the Second Hospital, Jilin University, Changchun, Jilin Province, China; 3 Department of Neurology, the First Hospital, Jilin University, Changchun, Jilin Province, China; 4 Emergency Medicine, the First Hospital, Jilin University, Changchun, Jilin Province, China)
Ma C, Zhu Z, Wang X, Zhao G, Liu XL, Li R. Vasopressin decreases neuronal apoptosis during cardiopulmonary resuscitation. Neural Regen Res. 2014;9(6):622-629.
Contact: Meng Zhao
Neural Regeneration Research
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.